NCT05255159View on ClinicalTrials.gov

Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors

PHASE2RecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Neuroendocrine Tumors

Interventions

DIAGNOSTIC_TEST

18F-DOPA with furosemide

Diagnostic 18F-DOPA PET/CT scan

Trial Locations (1)

T6G 2B7

RECRUITING

University of Alberta Hospital, Edmonton

All Listed Sponsors

lead

University of Alberta

OTHER